Atopic dermatitis: A global health perspective

Author:

Faye Ousmane1,Flohr Carsten23ORCID,Kabashima Kenji45,Ma Lin6,Paller Amy S.7ORCID,Rapelanoro Fahafahantsoa Rabenja8,Steinhoff Martin910111213,Su John C.1415,Takaoka Roberto1617,Wollenberg Andreas16171819ORCID,Yew Yik Weng20,Postigo Jose A. Ruiz21,Schmid‐Grendelmeier Peter16222324ORCID,Taïeb Alain1625ORCID

Affiliation:

1. Department of Dermatology, Faculty of Medicine and Odontostomatology Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) Bamako Mali

2. Paediatric & Population‐Based Dermatology Research St John's Institute of Dermatology London UK

3. Guy & St Thomas' NHS Foundation Trust and King's College London London UK

4. Department of Dermatology Kyoto University Graduate School of Medicine, Singapore Research Institute of Singapore (SRIS) Kyoto Japan

5. A*STAR Skin Research Labs (A*SRL), Agency for Science, Technology, and Research (A*STAR)Biopolis Singapore City Singapore

6. Department of Dermatology, Beijing Children's Hospital Capital Medical University Beijing China

7. Departments of Dermatology and Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois USA

8. Department of Dermatology Antananarivo University Antananarivo Madagascar

9. Department of Dermatology and Venereology Hamad Medical Corporation Doha Qatar

10. Translational Research Institute, Academic Health System Hamad Medical Corporation Doha Qatar

11. Dermatology Institute, Academic Health System Hamad Medical Corporation Doha Qatar

12. Weill Cornell Medicine‐Qatar Ar‐Rayyan Qatar

13. College of Medicine Qatar University Doha Qatar

14. Eastern Health Monash University Melbourne Victoria Australia

15. Murdoch Children's Research Institute University of Melbourne Melbourne Victoria Australia

16. International Society of Atopic Dermatitis Davos Switzerland

17. Division of Dermatology University of São Paulo Medical School Hospital São Paulo Brazil

18. University Hospital Augsburg Augsburg Germany

19. Ludwig‐Maximilian University Munich Germany

20. National Skin Centre Singapore City Singapore

21. WHO Department of Control of NTDs Geneva Switzerland

22. World Allergy Organization Milwaukee Wisconsin USA

23. Allergy Unit, Department of Dermatology University Hospital of Zurich Zurich Switzerland

24. Christine Kühne Center for Allergy Research and Education CK‐CARE Davos Switzerland

25. INSERM U 1312, University of Bordeaux Bordeaux France

Abstract

AbstractThe International Society of AD (ISAD) organized a roundtable on global aspects of AD at the WCD 2023 in Singapore. According to the Global Burden of Disease (GBD) consortium, at least 171 million individuals were affected with AD in 2019, corresponding to 2.23% of the world population, with age‐standardized prevalence and incidence rates that were relatively stable from 1990 to 2019. Based on the panel experience, most AD cases are mild‐to‐moderate. Without parallel data on disease prevalence and severity, the GBD data are difficult to interpret in many regions. This gap is particularly important in countries with limited medical infrastructure, but indirect evidence suggests a significant burden of AD in low‐and‐medium resource settings, especially urban areas. The Singapore roundtable was an opportunity to compare experiences in World Bank category 1 (Madagascar and Mali), 3 (Brazil, China) and 4 (Australia, Germany, Qatar, USA, Singapore, Japan) countries. The panel concluded that current AD guidelines are not adapted for low resource settings and a more pragmatic approach, as developed by WHO for skin NTDs, would be advisable for minimal access to moisturizers and topical corticosteroids. The panel also recommended prioritizing prevention studies, regardless of the level of existing resources. For disease long‐term control in World Bank category 3 and most category 4 countries, the main problem is not access to drugs for most mild‐to‐moderate cases, but rather poor compliance due to insufficient time at visits. Collaboration with WHO, patient advocacy groups and industry may promote global change, improve capacity training and fight current inequalities. Finally, optimizing management of AD and its comorbidities needs more action at the primary care level, because reaching specialist care is merely aspirational in most settings. Primary care empowerment with store and forward telemedicine and algorithms based on augmented intelligence is a future goal.

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Reference72 articles.

1. WallachD TillesG.Le premier congrès international de dermatologie et de syphiligraphie Paris 5–10 août 1889 [cited 2023 July 22]. Available from:https://www.biusante.parisdescartes.fr/sfhm/hsm/HSMx1990x024x002/HSMx1990x024x002x0099.pdf

2. Special discussion on prurigo, lichenification and allied conditions;Morris M;Br J Dermatol,1912

3. Childhood eczema: disease of the advantaged?

4. Position Statement on Atopic Dermatitis in Sub‐Saharan Africa: current status and roadmap

5. Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3